2020
DOI: 10.33920/med-01-2011-08
|View full text |Cite
|
Sign up to set email alerts
|

Application of stereotactic radiosurgery and radiotherapy in the treatment of Itsenko — Cushing’s disease

Abstract: Cushing’s disease is caused by a pituitary tumor which causes increased production of adrenocorticotropic hormone, leading to chronic hypersecretion of cortisol by the adrenal cortices. Endoscopic transnasal adenomectomy is the initial treatment of choice with the greatest efficiency for the treatment of the disease. However in the absence of remission or relapse of hypercortisolism after neurosurgical surgery, as well as in cases when surgical intervention cannot be carried due to medical contraindications to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…SRS is currently used to treat patients with a variety of processes including cerebral vascular malformations (arteriovenous malformations or AVMs [ 15 ] and cavernous angiomas [ 16 ]), benign tumors (meningiomas [ 17 - 18 ], vestibular schwannoma [ 19 ], pituitary adenoma [ 20 - 21 ], glomus jugulare tumors [ 22 ], low-grade glioma [ 23 ]), and malignant tumors (metastasis [ 24 ], chordoma [ 25 ], high-grade glioma [ 26 ]). Other less common indications are Cushing's disease [ 27 - 28 ], epilepsy [ 29 ], trigeminal neuralgia [ 30 ], and movement disorders [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…SRS is currently used to treat patients with a variety of processes including cerebral vascular malformations (arteriovenous malformations or AVMs [ 15 ] and cavernous angiomas [ 16 ]), benign tumors (meningiomas [ 17 - 18 ], vestibular schwannoma [ 19 ], pituitary adenoma [ 20 - 21 ], glomus jugulare tumors [ 22 ], low-grade glioma [ 23 ]), and malignant tumors (metastasis [ 24 ], chordoma [ 25 ], high-grade glioma [ 26 ]). Other less common indications are Cushing's disease [ 27 - 28 ], epilepsy [ 29 ], trigeminal neuralgia [ 30 ], and movement disorders [ 31 ].…”
Section: Discussionmentioning
confidence: 99%